Streamlined Schemes for Dosimetry of (177)Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer

SIMPLE SUMMARY: In patients with progressive metastasized castration-resistance prostate cancer PSMA radioligand therapies have shown promising results regarding clinical safety and efficacy. Dosimetry is mandatory due to legal regulations and also required for the estimation of doses to organs at r...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurth, Jens, Heuschkel, Martin, Tonn, Alexander, Schildt, Anna, Hakenberg, Oliver W., Krause, Bernd J., Schwarzenböck, Sarah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345627/
https://www.ncbi.nlm.nih.gov/pubmed/34359784
http://dx.doi.org/10.3390/cancers13153884

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345627/
https://www.ncbi.nlm.nih.gov/pubmed/34359784
http://dx.doi.org/10.3390/cancers13153884

Ejemplares similares